SLC22A9

gene
On this page

Also known as OAT4FLJ23666UST3OAT7

Summary

SLC22A9 (solute carrier family 22 member 9, HGNC:16261) is a protein-coding gene on chromosome 11q12.3, encoding Organic anion transporter 7 (Q8IVM8). Sodium-independent organic anion transporter, exhibits high specificity for sulfated conjugates of xenobiotics and steroid hormones such as estrone 3-sulfate (E1S) and dehydroepiandrosterone sulfate (DHEAS).

Enables short-chain fatty acid transmembrane transporter activity and sodium-independent organic anion transmembrane transporter activity. Involved in hormone transport; short-chain fatty acid transmembrane transport; and sodium-independent organic anion transport. Located in basolateral plasma membrane. Implicated in Lynch syndrome and mismatch repair cancer syndrome.

Source: NCBI Gene 114571 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 73 total
  • Druggable target: yes
  • MANE Select transcript: NM_080866

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:16261
Approved symbolSLC22A9
Namesolute carrier family 22 member 9
Location11q12.3
Locus typegene with protein product
StatusApproved
AliasesOAT4, FLJ23666, UST3, OAT7
Ensembl geneENSG00000149742
Ensembl biotypeprotein_coding
OMIM607579
Entrez114571

Gene structure

Transcript identifiers

Ensembl transcripts: 14 — 13 protein_coding, 1 nonsense_mediated_decay

ENST00000279178, ENST00000536333, ENST00000863020, ENST00000863021, ENST00000863022, ENST00000863023, ENST00000863024, ENST00000863025, ENST00000863026, ENST00000863027, ENST00000863028, ENST00000863029, ENST00000863030, ENST00000863031

RefSeq mRNA: 1 — MANE Select: NM_080866 NM_080866

CCDS: CCDS8043

Canonical transcript exons

ENST00000279178 — 10 exons

ExonStartEnd
ENSE000011192956337364463373798
ENSE000016578256340980263410294
ENSE000022150906336978563370458
ENSE000024849226337113563371238
ENSE000034858446337389463374062
ENSE000035497806340649763406711
ENSE000035871526340811263408220
ENSE000035904186338215963382277
ENSE000035944506337564563375768
ENSE000036836086340867663408879

Expression profiles

Bgee: expression breadth broad, 43 present calls, max score 83.61.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1117 / max 38.8015, expressed in 13 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1147900.111713

Top tissues by expression

233 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right lobe of liverUBERON:000111483.61gold quality
liverUBERON:000210781.46gold quality
Brodmann (1909) area 9UBERON:001354057.76gold quality
right frontal lobeUBERON:000281056.85gold quality
spermCL:000001956.80gold quality
upper leg skinUBERON:000426256.27silver quality
dorsolateral prefrontal cortexUBERON:000983455.49gold quality
skin of hipUBERON:000155454.86silver quality
sural nerveUBERON:001548854.71gold quality
anterior cingulate cortexUBERON:000983552.53gold quality
gall bladderUBERON:000211051.66gold quality
frontal cortexUBERON:000187051.22gold quality
neocortexUBERON:000195050.96gold quality
prefrontal cortexUBERON:000045150.71gold quality
primary visual cortexUBERON:000243649.44gold quality
cerebral cortexUBERON:000095649.08gold quality
occipital lobeUBERON:000202147.97gold quality
amygdalaUBERON:000187647.87gold quality
middle temporal gyrusUBERON:000277145.45gold quality
buccal mucosa cellCL:000233645.38gold quality
temporal lobeUBERON:000187145.04gold quality
islet of LangerhansUBERON:000000643.99gold quality
superior frontal gyrusUBERON:000266143.51gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451143.37gold quality
renal medullaUBERON:000036242.64gold quality
secondary oocyteCL:000065542.57gold quality
forebrainUBERON:000189042.39gold quality
skeletal muscle tissueUBERON:000113442.11gold quality
adrenal tissueUBERON:001830342.06gold quality
mammalian vulvaUBERON:000099741.84gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.09

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): HNF1A

miRNA regulators (miRDB)

20 targeting SLC22A9, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-129799.9173.413162
HSA-MIR-26A-5P99.7873.522303
HSA-MIR-26B-5P99.7873.512305
HSA-MIR-4524A-3P99.7266.852406
HSA-MIR-446599.7172.562096
HSA-MIR-4777-5P99.3367.531148
HSA-MIR-3064-5P99.2666.131497
HSA-MIR-3085-3P99.2666.161490
HSA-MIR-6504-5P99.2665.951487
HSA-MIR-149-5P99.2567.161315
HSA-MIR-6838-3P98.4065.88559
HSA-MIR-4733-3P98.3565.20994
HSA-MIR-807898.3265.73361
HSA-MIR-6742-3P97.9564.501490
HSA-MIR-449C-3P97.7567.86462
HSA-MIR-365297.7165.431890
HSA-MIR-443097.4765.611813
HSA-MIR-663B97.4062.91664
HSA-MIR-479496.4765.531063

Literature-anchored findings (GeneRIF, showing 12)

  • uptake of steroid sulfates by isolated trophoblasts is mediated by OATP-B and OAT-4 suggesting a physiological role of both carrier proteins in placental uptake of fetal-derived steroid sulfates. (PMID:12409283)
  • Both progesterone and activation of PKC inhibited hOAT4 activity through redistribution of the transporter from cell surface to the intracellular compartments. (PMID:17341544)
  • OAT7 is the first liver-specific transporter among members of the organic anion transporters of SLC22 family. (PMID:17393504)
  • The data provide a model for the concerted action of OAT1 mediating apical secretion of glutarate derivatives from proximal tubule cells (PMID:18365245)
  • The regulatory single nucleotide polymorphism (SNP) of OAT4 found in the promoter region of nephrectomized patients is unlikely to influence mRNA expression or promoter activity of OAT4. (PMID:18414781)
  • Review summarizes current knowledge on the functional and phenotypic consequences of genetic variation in intestinally, hepatically and renally expressed members of solute carrier family (SLC22) member 9. (PMID:18466105)
  • Functional differences in steroid uptake of SLC22A9 and SLC02B1 in human placenta are reported. (PMID:18501590)
  • Human organic anion transporter hOAT4 is a transporter of perfluorooctanoic acid. (PMID:19371258)
  • Pravastatin is the first identified OAT7 drug substrate. Substantial inter-individual variability in hepatic OAT7 expression, majorly driven by HNF4alpha, may contribute to pravastatin drug disposition and might affect response. (PMID:26239079)
  • two human organic anion transporters OAT2 and OAT7 activities were assessed. (PMID:28945155)
  • Large interindividual variability was noted in the hepatic expression of OAT2 (16-fold in human liver tissue and 23-fold in hepatocytes). OAT7, on the other hand, showed less interindividual variability (4-fold) in the livers, but high variability for the hepatocyte lots (27-fold). A significant positive correlation in OAT2 and OAT7 expression was observed, but expression levels were neither associated with age nor sex. (PMID:29906129)
  • The Membrane Transporter OAT7 (SLC22A9) Is Not a Susceptibility Factor for Osteoporosis in Europeans. (PMID:33013684)

Cross-species orthologs

60 orthologs

OrganismSymbolGene ID
danio_rerioslc22a4ENSDARG00000005335
danio_reriooatxENSDARG00000019713
danio_reriosi:dkey-166k12.1ENSDARG00000054690
danio_rerioslc22a15ENSDARG00000055445
danio_reriosi:dkey-119m7.4ENSDARG00000071049
danio_reriosi:dkey-119m7.8ENSDARG00000096654
mus_musculusSlc22a19ENSMUSG00000024757
mus_musculusSlc22a30ENSMUSG00000052562
mus_musculusSlc22a26ENSMUSG00000053303
mus_musculusSlc22a28ENSMUSG00000063590
mus_musculusSlc22a27ENSMUSG00000067656
mus_musculusSlc22a29ENSMUSG00000075044
rattus_norvegicusSlc22a25ENSRNOG00000017964
rattus_norvegicusUST4rENSRNOG00000049826
rattus_norvegicusAABR07006120.1ENSRNOG00000056396
rattus_norvegicusUst5rENSRNOG00000061890
drosophila_melanogasterOrctFBGN0019952
drosophila_melanogasterCG15221FBGN0030331
drosophila_melanogasterBalatFBGN0033778
drosophila_melanogasterCG4630FBGN0033809
drosophila_melanogasterCG5592FBGN0035645
drosophila_melanogasterCG10486FBGN0035647
drosophila_melanogasterSLC22AFBGN0037140
drosophila_melanogasterCG7458FBGN0037144
drosophila_melanogasterCG14691FBGN0037829
drosophila_melanogasterCG14855FBGN0038260
drosophila_melanogasterCG14856FBGN0038261
drosophila_melanogasterCG14857FBGN0038262
drosophila_melanogasterCG12783FBGN0038448
drosophila_melanogasterCG7333FBGN0038715
drosophila_melanogasterCG7342FBGN0038716
drosophila_melanogasterCG17751FBGN0038717
drosophila_melanogasterCG17752FBGN0038718
drosophila_melanogasterCG16727FBGN0038719
drosophila_melanogasterCG6231FBGN0038720
drosophila_melanogasterCG4465FBGN0038750
drosophila_melanogasterCG4462FBGN0038752
drosophila_melanogasterCG4459FBGN0038753
drosophila_melanogasterCG6356FBGN0039178
drosophila_melanogasterCG3690FBGN0040350
drosophila_melanogasterCG31103FBGN0051103
drosophila_melanogasterCG31106FBGN0051106
drosophila_melanogasterCG31272FBGN0051272
drosophila_melanogasterCG33233FBGN0053233
drosophila_melanogasterCG33234FBGN0053234
drosophila_melanogasterOrct2FBGN0086365
drosophila_melanogasterCG42269FBGN0259164
drosophila_melanogasterCG44098FBGN0264907
caenorhabditis_elegansWBGENE00003837
caenorhabditis_elegansoct-1WBGENE00003842
caenorhabditis_elegansWBGENE00003843
caenorhabditis_elegansWBGENE00006220
caenorhabditis_elegansWBGENE00008110
caenorhabditis_elegansWBGENE00011456
caenorhabditis_elegansWBGENE00014127
caenorhabditis_elegansWBGENE00015088
caenorhabditis_elegansWBGENE00017751
caenorhabditis_elegansWBGENE00019408
caenorhabditis_elegansWBGENE00020701
caenorhabditis_elegansWBGENE00044455

Paralogs (22): SLC22A16 (ENSG00000004809), SLC22A17 (ENSG00000092096), SLC22A2 (ENSG00000112499), SLC22A7 (ENSG00000137204), SLC22A23 (ENSG00000137266), SLC22A14 (ENSG00000144671), SLC22A3 (ENSG00000146477), SLC22A8 (ENSG00000149452), SVOPL (ENSG00000157703), SLC22A15 (ENSG00000163393), SVOP (ENSG00000166111), SLC22A11 (ENSG00000168065), SLC22A13 (ENSG00000172940), SLC22A1 (ENSG00000175003), SLC22A10 (ENSG00000184999), SLC22A25 (ENSG00000196600), SLC22A4 (ENSG00000197208), SLC22A5 (ENSG00000197375), SLC22A24 (ENSG00000197658), SLC22A12 (ENSG00000197891), SLC22A6 (ENSG00000197901), SLC22A31 (ENSG00000259803)

Protein

Protein identifiers

Organic anion transporter 7Q8IVM8 (reviewed: Q8IVM8)

Alternative names: Organic anion/short-chain fatty acid exchanger, Solute carrier family 22 member 9

All UniProt accessions (1): Q8IVM8

UniProt curated annotations — full annotation on UniProt →

Function. Sodium-independent organic anion transporter, exhibits high specificity for sulfated conjugates of xenobiotics and steroid hormones such as estrone 3-sulfate (E1S) and dehydroepiandrosterone sulfate (DHEAS). Can transport the statin pravastatin and may contribute to its disposition into the hepatocytes when the function of OATPs is compromised. It is specifically activated by 3 to 5 carbons-containing short-chain fatty acids/SCFAs, including propionate (propanoate), butyrate (butanoate) and valerate (pentanoate). May operate the exchange of sulfated organic components against short-chain fatty acids/SCFAs, in particular butanoate, at the sinusoidal membrane of hepatocytes.

Subcellular location. Basolateral cell membrane.

Tissue specificity. Specifically expressed in liver (also at protein level).

Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.

Similarity. Belongs to the major facilitator (TC 2.A.1) superfamily. Organic cation transporter (TC 2.A.1.19) family.

Isoforms (2)

UniProt IDNamesCanonical?
Q8IVM8-11yes
Q8IVM8-22

RefSeq proteins (1): NP_543142* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR011701MFSFamily
IPR020846MFS_domDomain
IPR036259MFS_trans_sfHomologous_superfamily

Pfam: PF07690

Catalyzed reactions (Rhea), 6 shown:

  • butanoate(out) + estrone 3-sulfate(in) = butanoate(in) + estrone 3-sulfate(out) (RHEA:72051)
  • propanoate(in) + estrone 3-sulfate(out) = propanoate(out) + estrone 3-sulfate(in) (RHEA:72555)
  • pentanoate(in) + estrone 3-sulfate(out) = pentanoate(out) + estrone 3-sulfate(in) (RHEA:72559)
  • dehydroepiandrosterone 3-sulfate(in) + butanoate(out) = dehydroepiandrosterone 3-sulfate(out) + butanoate(in) (RHEA:72563)
  • propanoate(out) + dehydroepiandrosterone 3-sulfate(in) = propanoate(in) + dehydroepiandrosterone 3-sulfate(out) (RHEA:72567)
  • pentanoate(out) + dehydroepiandrosterone 3-sulfate(in) = pentanoate(in) + dehydroepiandrosterone 3-sulfate(out) (RHEA:72571)

UniProt features (37 total): topological domain 13, transmembrane region 12, glycosylation site 3, sequence variant 3, splice variant 2, sequence conflict 2, chain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IVM8-F185.560.53

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (3): 39, 56, 102

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 63 (showing top): GOBP_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSPORT, GOBP_REGULATION_OF_HORMONE_LEVELS, GOBP_HORMONE_TRANSPORT, GOBP_ORGANIC_ACID_TRANSPORT, GOBP_ORGANIC_ANION_TRANSPORT, GOBP_MONOCARBOXYLIC_ACID_TRANSPORT, GOBP_LIPID_LOCALIZATION, GOBP_FATTY_ACID_TRANSPORT, GOBP_TRANSMEMBRANE_TRANSPORT, GOCC_PLASMA_MEMBRANE_REGION, GOCC_BASAL_PART_OF_CELL, GOMF_LIPID_TRANSPORTER_ACTIVITY, GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_MONOCARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, YOSHIMURA_MAPK8_TARGETS_UP

GO Biological Process (6): hormone transport (GO:0009914), obsolete organic anion transport (GO:0015711), short-chain fatty acid transmembrane transport (GO:0015913), sodium-independent organic anion transport (GO:0043252), lipid transport (GO:0006869), transmembrane transport (GO:0055085)

GO Molecular Function (4): obsolete organic anion transmembrane transporter activity (GO:0008514), obsolete sodium-independent organic anion transmembrane transporter activity (GO:0015347), short-chain fatty acid transmembrane transporter activity (GO:0015636), transmembrane transporter activity (GO:0022857)

GO Cellular Component (3): basolateral plasma membrane (GO:0016323), plasma membrane (GO:0005886), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transport3
short-chain fatty acid transport2
transmembrane transport2
regulation of hormone levels1
fatty acid transmembrane transport1
lipid localization1
cellular process1
fatty acid transmembrane transporter activity1
transporter activity1
basal plasma membrane1
plasma membrane region1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

842 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SLC22A9SLC47A2Q86VL8762
SLC22A9SLC47A1Q96FL8760
SLC22A9SLC2A9Q9NRM0723
SLC22A9ABCC4O15439703
SLC22A9SLCO2B1O94956702
SLC22A9SLCO1A2P46721691
SLC22A9SLCO4C1Q6ZQN7682
SLC22A9SLCO1B3Q9NPD5658
SLC22A9SLCO1B1Q9Y6L6653
SLC22A9SLC17A1Q14916645
SLC22A9ABCG2Q9UNQ0621
SLC22A9SLC17A3O00476611
SLC22A9SLCO4A1Q96BD0597
SLC22A9SLCO3A1Q9UIG8567
SLC22A9ABCC2Q92887561

IntAct

134 interactions, top by confidence:

ABTypeScore
SLC22A9GPR89Apsi-mi:“MI:0914”(association)0.530
SLC22A9MAST2psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9SNX27psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9SHANK1psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9TAMALINpsi-mi:“MI:0407”(direct interaction)0.440
MAGI2SLC22A9psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9MAST1psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9NHERF2psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9PDZK1psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9RHPN1psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9NHERF4psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9PARD3Bpsi-mi:“MI:0407”(direct interaction)0.440
PDZD7SLC22A9psi-mi:“MI:0407”(direct interaction)0.440
PTPN3SLC22A9psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9DLG3psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9TIAM2psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9SCRIBpsi-mi:“MI:0407”(direct interaction)0.440
APBA3SLC22A9psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9PDZRN4psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9DLG4psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9GRIP2psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9GOPCpsi-mi:“MI:0407”(direct interaction)0.440
SLC22A9SNTG2psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9PDZD2psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9SNTA1psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9MAGI3psi-mi:“MI:0407”(direct interaction)0.440
SLC22A9TJP1psi-mi:“MI:0407”(direct interaction)0.440

BioGRID (366): ELOVL2 (Affinity Capture-MS), TMEM242 (Affinity Capture-MS), CAV1 (Affinity Capture-MS), TMEM115 (Affinity Capture-MS), SLC25A51 (Affinity Capture-MS), ZDHHC21 (Affinity Capture-MS), TMEM67 (Affinity Capture-MS), SLC22A5 (Affinity Capture-MS), MFSD5 (Affinity Capture-MS), C20orf24 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), MFSD12 (Affinity Capture-MS), SLC35B2 (Affinity Capture-MS), DPY19L1 (Affinity Capture-MS), PIGW (Affinity Capture-MS)

ESM2 similar proteins: A0A3Q2IDB4, A0A8B7HA97, A4ZYQ5, A6NK97, G1SZD9, O35956, O57379, O88909, P22732, P23945, P43427, Q0IHM1, Q2KIV1, Q3ZAV1, Q4U2R8, Q4W8A2, Q4W8A3, Q5R9C4, Q5RC45, Q5RCH6, Q5RET7, Q63ZE4, Q66J52, Q6DFR1, Q6NUB3, Q6NYN7, Q6PXP3, Q6T423, Q70BM6, Q76M72, Q76M99, Q80UJ1, Q863Y9, Q864Z3, Q8CFZ5, Q8HY24, Q8IVM8, Q8MK48, Q8N4F4, Q8R0S9

Diamond homologs: A0A3Q2IDB4, A0A8B7HA97, A6NK97, A6QLW8, B2GV36, G1SZD9, O34691, O35956, O57379, O75751, O88446, O88909, Q1RPP5, Q28ES4, Q2KIV1, Q3YAW7, Q3ZAV1, Q4U2R8, Q4W8A2, Q4W8A3, Q5R540, Q5R9C4, Q5RC45, Q5RCH6, Q5RLM2, Q63ZE4, Q66J52, Q66J54, Q6A4L0, Q6NYN7, Q6T423, Q70BM6, Q76M72, Q76M99, Q80UJ1, Q864Z3, Q8CFZ5, Q8HY24, Q8IVM8, Q8MK48

SIGNOR signaling

1 interactions.

AEffectBMechanism
HNF1A“up-regulates quantity by expression”SLC22A9“transcriptional regulation”

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 87 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Ras activation upon Ca2+ influx through NMDA receptor551.9×2e-06
Unblocking of NMDA receptors, glutamate binding and activation549.4×2e-06
Negative regulation of NMDA receptor-mediated neuronal transmission549.4×2e-06
Long-term potentiation543.3×3e-06
Assembly and cell surface presentation of NMDA receptors941.5×6e-11
Neurexins and neuroligins1035.8×3e-11
Protein-protein interactions at synapses629.0×2e-06
RHOB GTPase cycle514.0×5e-04

GO biological processes:

GO termPartnersFoldFDR
establishment or maintenance of epithelial cell apical/basal polarity1178.0×3e-16
protein localization to synapse656.0×1e-07
receptor clustering753.3×1e-08
regulation of postsynaptic membrane neurotransmitter receptor levels742.3×4e-08
protein-containing complex assembly912.5×3e-06
cell-cell adhesion1012.4×6e-07
regulation of small GTPase mediated signal transduction58.8×5e-03
chemical synaptic transmission76.6×2e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

73 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance66
Likely benign7
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1325 predictions. Top by Δscore:

VariantEffectΔscore
11:63370456:GAG:Gdonor_gain1.0000
11:63370457:AGGT:Adonor_loss1.0000
11:63370459:G:GGdonor_gain1.0000
11:63370459:GTAA:Gdonor_loss1.0000
11:63370460:T:Adonor_loss1.0000
11:63373794:GTTAA:Gdonor_gain1.0000
11:63373795:T:Gdonor_gain1.0000
11:63373799:G:GGdonor_gain1.0000
11:63373892:A:AGacceptor_gain1.0000
11:63373893:G:GGacceptor_gain1.0000
11:63373893:GTA:Gacceptor_gain1.0000
11:63408880:G:GGdonor_gain1.0000
11:63371133:A:AGacceptor_gain0.9900
11:63371133:AGT:Aacceptor_gain0.9900
11:63371133:AGTG:Aacceptor_gain0.9900
11:63371134:G:GGacceptor_gain0.9900
11:63371134:GT:Gacceptor_gain0.9900
11:63371134:GTG:Gacceptor_gain0.9900
11:63371134:GTGG:Gacceptor_gain0.9900
11:63372023:C:Gdonor_gain0.9900
11:63373090:G:GGdonor_gain0.9900
11:63373795:T:TGdonor_gain0.9900
11:63373893:GT:Gacceptor_gain0.9900
11:63374156:A:AGacceptor_gain0.9900
11:63375638:T:TAacceptor_gain0.9900
11:63408198:G:GTdonor_gain0.9900
11:63408661:T:Aacceptor_gain0.9900
11:63408672:AAAG:Aacceptor_gain0.9900
11:63408773:T:TAacceptor_gain0.9900
11:63408875:AATGA:Adonor_gain0.9900

AlphaMissense

3646 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
11:63370063:T:CF3L0.967
11:63370065:T:AF3L0.967
11:63370065:T:GF3L0.967
11:63408676:G:CR466S0.963
11:63408676:G:TR466S0.963
11:63370201:T:AC49S0.956
11:63370202:G:CC49S0.956
11:63370327:T:CF91L0.955
11:63370329:T:AF91L0.955
11:63370329:T:GF91L0.955
11:63370174:T:CF40L0.948
11:63370176:C:AF40L0.948
11:63370176:C:GF40L0.948
11:63406648:A:CS409R0.947
11:63406650:C:AS409R0.947
11:63406650:C:GS409R0.947
11:63371137:G:CW135C0.945
11:63371137:G:TW135C0.945
11:63406583:G:AG387D0.945
11:63408717:C:AA480E0.945
11:63373653:A:CR172S0.943
11:63373653:A:TR172S0.943
11:63375710:T:CL299P0.943
11:63408147:G:CG442R0.943
11:63370064:T:GF3C0.941
11:63373756:G:TG207W0.941
11:63373902:T:AW224R0.940
11:63373902:T:CW224R0.940
11:63406582:G:CG387R0.939
11:63408148:G:AG442D0.936

dbSNP variants (sampled 300 via entrez): RS1000017730 (11:63386402 A>G), RS1000018220 (11:63403064 A>G), RS1000043784 (11:63393510 A>G), RS1000074203 (11:63399155 A>C), RS1000090401 (11:63409040 C>A), RS1000140416 (11:63381295 C>T), RS1000157045 (11:63396928 T>A), RS1000452814 (11:63394413 G>A,T), RS1000615665 (11:63385116 T>TTTG,TTTGTTGTTGTTGTTG), RS1000722113 (11:63384035 G>A), RS1000789204 (11:63391277 A>G), RS1001005930 (11:63404845 G>C), RS1001095715 (11:63407782 C>T), RS1001145193 (11:63384309 C>A,G), RS1001147594 (11:63368468 A>G)

Disease associations

OMIM: gene MIM:607579 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST001519_1Economic and political preferences3.000000e-06
GCST002925_7Sex hormone levels8.000000e-12
GCST007428_1Thyroxine levels4.000000e-07

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004827economic and social preference
EFO:0004730hormone measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL2073721 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — Organic anion transporters (OATs)

CTD chemical–gene interactions

48 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cyclosporinedecreases expression3
Aflatoxin B1decreases expression, decreases methylation, affects expression3
estrone sulfatedecreases reaction, increases uptake, increases import2
sodium arsenitedecreases expression, increases expression2
Benzo(a)pyreneaffects methylation, decreases expression, increases methylation2
Probenecidincreases import, increases uptake, decreases activity, decreases reaction2
OTX015decreases expression1
methyleugenoldecreases expression1
senecioninedecreases expression1
senkirkinedecreases expression1
heliotrinedecreases expression1
4-O-methyl-12-O-tetradecanoylphorbol 13-acetatedecreases activity1
pranlukastdecreases reaction, increases uptake1
losartan carboxylic aciddecreases reaction, increases uptake1
candesartan cilexetildecreases reaction, increases uptake1
candesartandecreases reaction, increases uptake1
Valsartandecreases reaction, increases uptake1
Rosiglitazonedecreases expression1
Acetaminophendecreases activity1
Anionsincreases uptake, decreases reaction1
Aspirindecreases activity1
Diclofenacdecreases activity1
Estradioldecreases expression1
Ibuprofendecreases activity, increases uptake1
Indomethacindecreases activity, increases uptake1
Ketoprofendecreases activity, increases uptake1
Mefenamic Aciddecreases activity1
Naproxendecreases activity1
Phenacetindecreases activity1
Phenobarbitalaffects expression1

ChEMBL screening assays

14 unique, capped per target: 14 functional

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL2075905FunctionalTP_TRANSPORTER: inhibition of carnitine uptake by Carnitine-related compound-9A at 20uM in Xenopus laevis oocytesMolecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. — J Biol Chem

Cellosaurus cell lines

2 cell lines: 2 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_D4SEHuH7-SLC22A9-KO-c4Cancer cell lineMale
CVCL_D4SFHuH7-SLC22A9-KO-c5Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.